1. Home
  2. CODX vs GROW Comparison

CODX vs GROW Comparison

Compare CODX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • GROW
  • Stock Information
  • Founded
  • CODX 2013
  • GROW 1968
  • Country
  • CODX United States
  • GROW United States
  • Employees
  • CODX N/A
  • GROW N/A
  • Industry
  • CODX Medical/Dental Instruments
  • GROW Investment Managers
  • Sector
  • CODX Health Care
  • GROW Finance
  • Exchange
  • CODX Nasdaq
  • GROW Nasdaq
  • Market Cap
  • CODX 39.3M
  • GROW 32.4M
  • IPO Year
  • CODX 2017
  • GROW N/A
  • Fundamental
  • Price
  • CODX $1.06
  • GROW $2.45
  • Analyst Decision
  • CODX Hold
  • GROW
  • Analyst Count
  • CODX 1
  • GROW 0
  • Target Price
  • CODX $1.50
  • GROW N/A
  • AVG Volume (30 Days)
  • CODX 90.9K
  • GROW 78.0K
  • Earning Date
  • CODX 11-07-2024
  • GROW 11-07-2024
  • Dividend Yield
  • CODX N/A
  • GROW 3.66%
  • EPS Growth
  • CODX N/A
  • GROW N/A
  • EPS
  • CODX N/A
  • GROW 0.12
  • Revenue
  • CODX $7,321,012.00
  • GROW $10,008,000.00
  • Revenue This Year
  • CODX N/A
  • GROW N/A
  • Revenue Next Year
  • CODX N/A
  • GROW N/A
  • P/E Ratio
  • CODX N/A
  • GROW $20.14
  • Revenue Growth
  • CODX 57.16
  • GROW N/A
  • 52 Week Low
  • CODX $1.00
  • GROW $2.38
  • 52 Week High
  • CODX $2.23
  • GROW $3.11
  • Technical
  • Relative Strength Index (RSI)
  • CODX 34.55
  • GROW 49.01
  • Support Level
  • CODX $1.02
  • GROW $2.38
  • Resistance Level
  • CODX $1.09
  • GROW $2.45
  • Average True Range (ATR)
  • CODX 0.05
  • GROW 0.05
  • MACD
  • CODX -0.01
  • GROW 0.00
  • Stochastic Oscillator
  • CODX 21.74
  • GROW 46.67

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: